S. 1722

One Hundred Fifth Congress

of the

United States of America

AT THE SECOND SESSION

Begun and held at the City of Washington on Tuesday,

the twenty-seventh day of January, one thousand nine hundred and ninety-eight

An Act

To amend the Public Health Service Act to revise and extend certain programs

with respect to women’s health research and prevention activities at the National

Institutes of Health and the Centers for Disease Control and Prevention.

Be it enacted by the Senate and House of Representatives of

the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ‘‘Women’s Health Research and

Prevention Amendments of 1998’’.

TITLE I—PROVISIONS RELATING TO

WOMEN’S HEALTH RESEARCH AT NATIONAL INSTITUTES OF HEALTH

SEC. 101. RESEARCH ON DRUG DES; NATIONAL PROGRAM OF EDUCATION.

(a) RESEARCH.—Section 403A(e) of the Public Health Service

Act (42 U.S.C. 283a(e)) is amended by striking ‘‘1996’’ and inserting

‘‘2003’’.

(b) NATIONAL PROGRAM FOR EDUCATION OF HEALTH PROFESSIONALS AND PUBLIC.—Title XVII of the Public Health Service Act

(42 U.S.C. 300u et seq.) is amended by adding at the end the

following:

‘‘EDUCATION REGARDING DES

‘‘SEC. 1710. (a) IN GENERAL.—The Secretary, acting through

the heads of the appropriate agencies of the Public Health Service,

shall carry out a national program for the education of health

professionals and the public with respect to the drug

diethylstilbestrol (commonly known as DES). To the extent appropriate, such national program shall use methodologies developed

through the education demonstration program carried out under

section 403A. In developing and carrying out the national program,

the Secretary shall consult closely with representatives of nonprofit

private entities that represent individuals who have been exposed

to DES and that have expertise in community-based information

campaigns for the public and for health care providers. The

implementation of the national program shall begin during fiscal

year 1999.

‘‘(b) AUTHORIZATION OF APPROPRIATIONS.—For the purpose of

carrying out this section, there are authorized to be appropriated
S. 1722—2

such sums as may be necessary for each of the fiscal years 1999

through 2003. The authorization of appropriations established in

the preceding sentence is in addition to any other authorization

of appropriation that is available for such purpose.’’.

SEC. 102. RESEARCH ON OSTEOPOROSIS, PAGET’S DISEASE, AND

RELATED BONE DISORDERS.

Section 409A(d) of the Public Health Service Act (42 U.S.C.

284e(d)) is amended by striking ‘‘and 1996’’ and inserting ‘‘through

2003’’.

SEC. 103. RESEARCH ON CANCER.

(a) RESEARCH ON BREAST CANCER.—Section 417B(b)(1) of the

Public Health Service Act (42 U.S.C. 286a–8(b)(1)) is amended—

(1) in subparagraph (A), by striking ‘‘and 1996’’ and inserting ‘‘through 2003’’; and

(2) in subparagraph (B), by striking ‘‘and 1996’’ and inserting ‘‘through 2003’’.

(b) RESEARCH ON OVARIAN AND RELATED CANCER RESEARCH.—

Section 417B(b)(2) of the Public Health Service Act (42 U.S.C.

286a–8(b)(2)) is amended by striking ‘‘and 1996’’ and inserting

‘‘through 2003’’.

SEC. 104. RESEARCH ON HEART ATTACK, STROKE, AND OTHER

CARDIOVASCULAR DISEASES IN WOMEN.

Subpart 2 of part C of title IV of the Public Health Service

Act (42 U.S.C. 285b et seq.) is amended by inserting after section

424 the following:

‘‘HEART ATTACK, STROKE, AND OTHER CARDIOVASCULAR DISEASES IN

WOMEN

‘‘SEC. 424A. (a) IN GENERAL.—The Director of the Institute

shall expand, intensify, and coordinate research and related activities of the Institute with respect to heart attack, stroke, and other

cardiovascular diseases in women.

‘‘(b) COORDINATION WITH OTHER INSTITUTES.—The Director of

the Institute shall coordinate activities under subsection (a) with

similar activities conducted by the other national research institutes

and agencies of the National Institutes of Health to the extent

that such Institutes and agencies have responsibilities that are

related to heart attack, stroke, and other cardiovascular diseases

in women.

‘‘(c) CERTAIN PROGRAMS.—In carrying out subsection (a), the

Director of the Institute shall conduct or support research to expand

the understanding of the causes of, and to develop methods for

preventing, cardiovascular diseases in women. Activities under such

subsection shall include conducting and supporting the following:

‘‘(1) Research to determine the reasons underlying the

prevalence of heart attack, stroke, and other cardiovascular

diseases in women, including African-American women and

other women who are members of racial or ethnic minority

groups.

‘‘(2) Basic research concerning the etiology and causes of

cardiovascular diseases in women.

‘‘(3) Epidemiological studies to address the frequency and

natural history of such diseases and the differences among
S. 1722—3

men and women, and among racial and ethnic groups, with

respect to such diseases.

‘‘(4) The development of safe, efficient, and cost-effective

diagnostic approaches to evaluating women with suspected

ischemic heart disease.

‘‘(5) Clinical research for the development and evaluation

of new treatments for women, including rehabilitation.

‘‘(6) Studies to gain a better understanding of methods

of preventing cardiovascular diseases in women, including

applications of effective methods for the control of blood pressure, lipids, and obesity.

‘‘(7) Information and education programs for patients and

health care providers on risk factors associated with heart

attack, stroke, and other cardiovascular diseases in women,

and on the importance of the prevention or control of such

risk factors and timely referral with appropriate diagnosis and

treatment. Such programs shall include information and education on health-related behaviors that can improve such important risk factors as smoking, obesity, high blood cholesterol,

and lack of exercise.

‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the purpose of

carrying out this section, there are authorized to be appropriated

such sums as may be necessary for each of the fiscal years 1999

through 2003. The authorization of appropriations established in

the preceding sentence is in addition to any other authorization

of appropriation that is available for such purpose.’’.

SEC. 105. AGING PROCESSES REGARDING WOMEN.

Section 445H of the Public Health Service Act (42 U.S.C. 285e–

10) is amended—

(1) by striking ‘‘The Director’’ and inserting ‘‘(a) The Director’’; and

(2) by adding at the end the following subsection:

‘‘(b) For the purpose of carrying out this section, there are

authorized to be appropriated such sums as may be necessary

for each of the fiscal years 1999 through 2003. The authorization

of appropriations established in the preceding sentence is in addition to any other authorization of appropriation that is available

for such purpose.’’.

SEC. 106. OFFICE OF RESEARCH ON WOMEN’S HEALTH.

Section 486(d)(2) of the Public Health Service Act (42 U.S.C.

287d(d)(2)) is amended by striking ‘‘Director of the Office’’ and

inserting ‘‘Director of NIH’’.

TITLE II—PROVISIONS RELATING TO

WOMEN’S HEALTH AT CENTERS FOR

DISEASE CONTROL AND PREVENTION

SEC. 201. NATIONAL CENTER FOR HEALTH STATISTICS.

Section 306(n) of the Public Health Service Act (42 U.S.C.

242k(n)) is amended—

(1) in paragraph (1), by striking ‘‘through 1998’’ and inserting ‘‘through 2003’’; and
S. 1722—4

(2) in paragraph (2), by striking ‘‘through 1998’’ and inserting ‘‘through 2003’’.

SEC. 202. NATIONAL PROGRAM OF CANCER REGISTRIES.

Section 399L(a) of the Public Health Service Act (42 U.S.C.

280e–4(a)) is amended by striking ‘‘through 1998’’ and inserting

‘‘through 2003’’.

SEC. 203. NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM.

(a) SERVICES.—Section 1501(a)(2) of the Public Health Service

Act (42 U.S.C. 300k(a)(2)) is amended by inserting before the semicolon the following: ‘‘and support services such as case management’’.

(b) PROVIDERS OF SERVICES.—Section 1501(b) of the Public

Health Service Act (42 U.S.C. 300k(b)) is amended—

(1) in paragraph (1), by striking ‘‘through grants’’ and all

that follows and inserting the following: ‘‘through grants to

public and nonprofit private entities and through contracts

with public and private entities.’’; and

(2) by striking paragraph (2) and inserting the following:

‘‘(2) CERTAIN APPLICATIONS.—If a nonprofit private entity

and a private entity that is not a nonprofit entity both submit

applications to a State to receive an award of a grant or

contract pursuant to paragraph (1), the State may give priority

to the application submitted by the nonprofit private entity

in any case in which the State determines that the quality

of such application is equivalent to the quality of the application

submitted by the other private entity.’’.

(c) AUTHORIZATIONS OF APPROPRIATIONS.—

(1) SUPPLEMENTAL GRANTS FOR ADDITIONAL PREVENTIVE

HEALTH SERVICES.—Section 1509(d)(1) of the Public Health

Service Act (42 U.S.C. 300n–4a(d)(1)) is amended by striking

‘‘through 1998’’ and inserting ‘‘through 2003’’.

(2) GENERAL PROGRAM.—Section 1510(a) of the Public

Health Service Act (42 U.S.C. 300n–5(a)) is amended by striking

‘‘through 1998’’ and inserting ‘‘through 2003’’.
S. 1722—5

SEC. 204. CENTERS FOR RESEARCH AND DEMONSTRATION OF

HEALTH PROMOTION.

Section 1706(e) of the Public Health Service Act (42 U.S.C.

300u–5(e)) is amended by striking ‘‘through 1998’’ and inserting

‘‘through 2003’’.

Speaker of the House of Representatives.

Vice President of the United States and

President of the Senate.